Eccogene's $60M milestone from AstraZeneca: The payment arrived after Eccogene met several milestones, including dosing the first ...

Evotec stock is up following progress in its partnership with Bristol Myers Squibb, including a $50 million payment.

Evotec announced in May of 2022 that the Company has further extended and expanded its partnership with Bristol Myers Squibb for another 8 years as the initial collaboration proved to be highly ...

Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology Evotec ...

Evotec (EVO) announced progress within the company’s strategic partnership with Bristol Myers Squibb (BMY) relating to building a molecular glue-based pipeline. Key scientific achievements drive the ...

Evotec International GmbH and Nosopharm SAS have jointly described odilorhabdin analogues reported to be useful for the treatment of multidrug-resistant bacterial infections.

The event, organised for Thursday, November 28 at The Guildhall, will run from 4pm to 6pm and will feature presentations from Wiltshire Police, Venture Security and EvoTec. Superintendent Douglas ...

The Salisbury Chamber of Commerce has announced their inaugural Salisbury Security Forum 2024 to be held on November 28th at ...

The impact of positive data on TPM502 could extend beyond celiac disease. As Topas’ lead candidate, TPM502 is serving as a ...

Global In-Vitro Toxicology Testing Market was valued at US$ 24.18 billion in 2023 and is projected to hit the market valuation of US$ 54.52 billion by 2032 at a CAGR of 9.23% during the forecast ...

Jefferies Financial Group cut shares of Evotec (NASDAQ:EVO – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, MarketBeat.com reports.

Evotec is a German contract research organization (CRO). CROs are a type of life sciences company that carry out clinical research for other biotech and pharmaceutical companies. Evotec has dozens of ...